Name William F. Fearon
Country United States
Job Interventional Cardiologist

Other content(s) by This Operator

  1. Physiologic Study and PCI
  2. Physiologic Assessment of Coronary Microvascular Dysfunction
  3. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR guided PCI to Angio guided PCI in Patients with Multivessel CAD
  4. FFR-Guided PCI
  5. Fractional Flow Reserve: Concept and Practical Set Up
  6. Fundamentals, Techniques, Pitfalls, and Limitations of FFR Interpretation and Measurement
  7. FFR in Multivessel Disease: Results of the F.A.M.E. Multicenter, International, Randomized Study Comparing FFR Guided PCI to Angio Guided PCI in Patients with Multivessel CAD
  8. Practice Guideline for FFR Use (FAME Study)
  9. Integrated Decision Making in Bifurcation Lesion (IVUS vs. FFR)
  10. FFR Guided PCI
  11. When to Use IVUS and When Would FFR Be a Better Choice?
  12. Beyond FAME: The Integration of Invasive Ischemia Assessment(FFR) into Clinical Practice
  13. FFR Clinical Trials and Applications: Make the PCI Practice Changed
  14. Gap Between Anatomy and Function
  15. How and Why to Assess the Coronary Microvasculature
  16. Sidebranch Compromise: Mechanism and Implication
  17. Clinical Application of IMR : Evidence and Practice
  18. Roles of FFR in Unstable Angina and NSTEMI
  19. Update 2013: FFR-guided Decision Making
  20. FAME2 & COURAGE Trials: Going Functional, It\'s Solution!
  21. FFR in Acute Coronary Syndrome: Culprit and Non-culprit Lesion
  22. Importance of the Coronary Microvasculature
  23. How to Integrate FAME I, FAME II and COURAGE?
  24. Tips and Trick
  25. Clinical Benefit of FFR
  26. FFR Evaluation: Optimal Measurement and Common Mistakes
  27. FFR Clinical Trials: Review and Update
  28. [FFR Use at CathLab: More & Better] Unmet Need: FAME 3
  29. For Ischemia, Forget VP and Focus on the Ischemic Lesion!
  30. Assessment and Clinical Relevance of Coronary Microvasculature
  31. Experimental Basis and Clinical Validation of FFR
  32. Update of the FAME 3 Trial
  33. Practical Set-up
  34. MVD and FAME Studies
  35. FFR State-of-the-Art: Clinical Applications and New Technologies
  36. The Ultimate: FAME 3
  37. Integrated Use of IMR and FFR in Daily Practice
  38. Invasive Evaluation of the Patient with Chest Pain and No Obstructive CAD
  39. Who Needs Adenosine or iFR, I Have cFFR (Contrast FFR): Update on the CONTRAST Study
  40. Update on FAME 3 Trial
  41. Coronary Blood Flow, Pressure and Resistance: How to Integrate, Interpret and Apply in Practice
  42. Left Main
  43. FFR Is Underutilized - Beyond Just Intermediate Lesions!
  44. Routine Assessment of the Microcirculation and Absolute Flow: A Glimpse to the Future
  45. The FUTURE Trial and Current Evidence of FFR Guided PCI: Is There Warning Sign?
  46. Are We Ready to Move from FFR to Resting Indices?
  47. Post-PCI FFR: What Does It Mean and Should We Measure It?
  48. PCI vs. CABG in LM and MVD: Time to Apply FFR for Decision-Making: Updated Data and FAME-3
  49. Is Anatomic Complete Revascularization Really Necessary?
  50. FFR Is Still Standard!
  51. Non-Invasive FFR Assessment
  52. Many Pressure Wires in Cath Lab: Advantages and Disadvantages
  53. FAME 2: 3-year Clinical and Cost-effectiveness Outcomes of FFR-guided PCI in Patients with Coronary Artery Disease
  54. FAST FFR
  55. FAME III: The Lessons from FAME Studies, What We Learned
  56. Angio-guided vs. FFR-guided PCI
  57. Complete Revascularization for MVD and LM: Anatomic or Functional Concept
  58. Angiography-derived Coronary Physiology